In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily glargine at 52 wk.
Where this comes from
- Record sourced from PubMed, PMID 37782932.
- Also identified by DOI 10.7326/J23-0079.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rosenstock J, Bain SC, Gowda A, et al; ONWARDS 1 Trial Investigators. <b>Weekly icodec versus daily glargine U100 in type 2 diabetes without previous insulin.</b> N Engl J Med. 2023;389:297-308. 37356066.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemia